Creatine for Women’s Brains: 28 Days to a Sharper Mind?
November 19, 2026Best Inositol in Canada (2026)
November 20, 2026Quick Summary
Inositol is one of the most talked-about supplements for PCOS, and women trying to conceive have bought it on the strength of glowing stories online. A new Cochrane review pulled together 21 trials and 1,634 women to test whether it actually helps — and the honest answer is: we still don’t really know. The evidence was rated low to very low certainty, and no trial has proven more live births. There are some encouraging hints, but they are thin.
Scroll through any PCOS forum and inositol sounds like a sure thing. Women swap dosage tips, post about cycles returning, and call it the one supplement that finally made sense. Now the gold standard of evidence reviews has weighed in — and its verdict is far less confident.
| Topic | What the research shows |
|---|---|
| The review | Cochrane review, published November 18, 2026: 21 trials, 1,634 women with PCOS and infertility |
| What was tested | Myo-inositol versus no treatment or metformin, during ovulation induction, IUI, or IVF |
| Live births | No clear answer — the evidence is too weak to say either way |
| Clinical pregnancy (IVF) | May be slightly higher with inositol (odds ratio 2.34), but the evidence is low certainty |
| The catch | Almost every finding was rated low or very low certainty |
| Bottom line | Encouraging hints, no proof — don’t treat it as a fertility plan on its own |
What 21 Trials Actually Found
The review, led by researchers at the University of Auckland, updates Cochrane’s earlier look at the topic. Sixteen of the 21 studies were new, and every study with usable data tested myo-inositol, the form in most supplements.
The headline result is a shrug. For women going through ovulation induction or intrauterine insemination, only one study of 120 women measured live births. It reported higher odds with inositol, but the reviewers rated the evidence very low certainty — too fragile to trust. For women going through IVF, two small studies with 84 women between them left the same question unanswered.
The one glimmer came from clinical pregnancy rates during IVF. Across three studies and 164 women, inositol may have slightly increased the chance of a clinical pregnancy, with an odds ratio of 2.34. That sounds big, but the rating is low certainty and the sample is small. A clinical pregnancy is also not the same as a baby going home — and on live births, the review could not give an answer.
The comparison with metformin, the drug many doctors prescribe first for PCOS, was just as thin: a single study of 102 women, very low certainty, no clear winner. The reviewers’ own conclusion says it plainly — they are unsure whether myo-inositol has an effect on live birth, miscarriage, or clinical pregnancy in women with PCOS and infertility.
Why the Hype Ran Ahead of the Science
None of this means inositol does nothing. The story here is the gap between what small, hopeful studies suggest and what rigorous reviews can confirm. Inositol makes biological sense for PCOS: the condition often involves insulin resistance, and inositol acts as a messenger that helps cells respond to insulin. That plausible mechanism, plus a wave of positive small trials, built the reputation.
The 2023 International PCOS Guideline’s own review of 30 trials found inositol roughly doubled ovulation rates versus placebo and improved fasting insulin, with far fewer stomach side effects than metformin. Yet the same review called the evidence “limited and inconclusive,” and the guideline only says inositol “could be considered.” Ovulation is a step toward pregnancy, not proof of it, and the trials were mostly small and short.
Even the famous 40:1 ratio — 4,000 mg of myo-inositol to 100 mg of D-chiro-inositol a day — rests on a single dose-finding trial of 56 women, just eight per group. It may be the right ratio, but it became supplement gospel on very little data. Meanwhile, the field itself is still shifting: in May 2026, PCOS was formally renamed polyendocrine metabolic ovarian syndrome, a reminder that researchers are still rethinking the condition itself.
What is inositol and how is it supposed to work?
Inositol is a sugar-like compound your body makes, mostly in the kidneys, and you also get it from fruit, beans, and whole grains. Myo-inositol is the main form, making up roughly 99% of the inositol inside a healthy ovary. Inside cells, it works as a second messenger, helping insulin and follicle-stimulating hormone (FSH) deliver their signals.
In PCOS, the picture gets tangled. Muscle cells may resist insulin while ovarian tissue stays sensitive to it. High insulin levels push an enzyme in the ovary to convert too much myo-inositol into D-chiro-inositol, draining the ovary of the myo-inositol it needs for FSH signaling. Researchers call this the DCI paradox, and it is why most products use myo-inositol alone or a 40:1 blend of myo to D-chiro — matching the ratio in healthy blood — rather than high-dose D-chiro on its own.
What are the side effects of inositol?
Inositol is generally well tolerated — a genuine part of its appeal. The most common side effects are mild stomach issues: loose stools, nausea, and gas, mostly at the highest doses studied, around 12 grams a day. At the 2 to 4 grams used in most PCOS trials, stomach upset is uncommon, and inositol caused far fewer gut side effects than metformin.
A few cautions still apply. If you take medication for blood sugar, lithium, or epilepsy drugs, mention inositol to your prescriber. High-dose D-chiro-inositol on its own is the one form researchers worry may work against ovulation, so the ratio on the label matters. And while inositol is sometimes used during pregnancy, any decision in pregnancy should go through your clinician first.
How much inositol should you take?
Most PCOS trials used 4 grams of myo-inositol a day, split into 2 grams twice daily and often paired with folic acid, for three to six months. Combination products typically follow the 40:1 pattern: 4,000 mg of myo-inositol plus 100 mg of D-chiro-inositol per day, split across two doses. Most studies saw changes only after eight to twelve weeks.
More is not better. Doses far above the studied range mostly add stomach upset, not results. And the honest caveat from the guideline review is that no specific type, dose, or combination can be formally recommended yet. If you try inositol, the studied dose — 2 grams twice a day — is the sensible anchor, and your doctor is the right person to fit it into a real fertility plan.
What should you look for on the label?
Start with a valid NPN. Inositol is a recognized natural health product ingredient in Canada, so a legitimate product should carry an eight-digit Natural Product Number — proof Health Canada has licensed it. Next, check the form: myo-inositol, or a 40:1 myo-to-D-chiro blend, with actual amounts printed per serving. A product hiding behind a proprietary blend, or listing a token sprinkle of inositol among a dozen other ingredients, is not what the trials used. Look for third-party testing, and a dose per serving close to 2 grams. Canadian-made is a plus.
References
- Vercoe, M. A., Rodenburg, C., Mackenzie-Proctor, R., Jordan, V. M., Hodgson, R., Farquhar, C., & Showell, M. G. (2026). Inositol for infertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, 11, CD012378. https://pubmed.ncbi.nlm.nih.gov/43049177/
- Fitz, V., Graca, S., Mahalingaiah, S., Liu, J., Lai, L., Butt, A., Armour, M., Rao, V., Naidoo, D., Maunder, A., Yang, G., Vaddiparthi, V., Witchel, S. F., Pena, A., Spritzer, P. M., Li, R., Tay, C., Mousa, A., Teede, H., & Ee, C. (2024). Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. The Journal of Clinical Endocrinology & Metabolism, 109(6), 1630–1655. https://doi.org/10.1210/clinem/dgad762
- Health Canada. (n.d.). Inositol — Natural Health Products Ingredients Database. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq?id=1525
This article reports on recent health research and is for general information only — it isn’t medical advice and doesn’t replace your doctor, pharmacist, or another qualified professional. Study findings describe what researchers observed, not a promise of results, and nothing here claims any supplement can diagnose, treat, cure, or prevent a disease. These statements have not been evaluated by Health Canada. Check with a healthcare professional before starting any new supplement, especially if you’re pregnant, nursing, taking medication, or managing a health condition.
